Cargando…

Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients

Background: Literature review suggests that adherence to immunosuppressive drugs may be lower in recipients of living than of deceased donor kidney grafts, possibly because of profile differences. Objective: To compare the level of immunosuppressive adherence levels between patients with deceased an...

Descripción completa

Detalles Bibliográficos
Autores principales: Denhaerynck, K., Schmid-Mohler, G., Kiss, A., Steiger, J., Wüthrich, R. P., Bock, A., De Geest, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Organ Transplantation Institute 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089329/
https://www.ncbi.nlm.nih.gov/pubmed/25013673
_version_ 1782325112523980800
author Denhaerynck, K.
Schmid-Mohler, G.
Kiss, A.
Steiger, J.
Wüthrich, R. P.
Bock, A.
De Geest, S.
author_facet Denhaerynck, K.
Schmid-Mohler, G.
Kiss, A.
Steiger, J.
Wüthrich, R. P.
Bock, A.
De Geest, S.
author_sort Denhaerynck, K.
collection PubMed
description Background: Literature review suggests that adherence to immunosuppressive drugs may be lower in recipients of living than of deceased donor kidney grafts, possibly because of profile differences. Objective: To compare the level of immunosuppressive adherence levels between patients with deceased and living (-related; -unrelated) donor grafts in Switzerland. Methods: Using data from two similar cross-sectional studies at two transplant centers in Switzerland, the level of adherence between the two groups was compared. Medication adherence was assessed by self-report or electronic monitoring. Possible explanatory factors included age, beliefs regarding immunosuppressive drugs, depressive symptomatology, pre-emptive transplantation, and the number of transplants received, were also considered. Data were analyzed using logistic regression analysis. Results: Unadjusted non-adherence odds were 2 to 3 times higher in living-related than deceased donor transplantation (ORs: 2.09-3.05; p<0.05). Adjustment for confounders showed that these differences were associated most with the younger age of living-related subjects and the belief that immunosuppressive drugs are less important for living-related donations. Conclusion: There is a lower immunosuppressive adherence in recipients of living-related donor kidneys, possibly owing to differences in patient profile (ie, health beliefs regarding their immunosuppressive needs), knowledge of which may enhance adherence if addressed.
format Online
Article
Text
id pubmed-4089329
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Avicenna Organ Transplantation Institute
record_format MEDLINE/PubMed
spelling pubmed-40893292014-07-10 Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients Denhaerynck, K. Schmid-Mohler, G. Kiss, A. Steiger, J. Wüthrich, R. P. Bock, A. De Geest, S. Int J Organ Transplant Med Original Article Background: Literature review suggests that adherence to immunosuppressive drugs may be lower in recipients of living than of deceased donor kidney grafts, possibly because of profile differences. Objective: To compare the level of immunosuppressive adherence levels between patients with deceased and living (-related; -unrelated) donor grafts in Switzerland. Methods: Using data from two similar cross-sectional studies at two transplant centers in Switzerland, the level of adherence between the two groups was compared. Medication adherence was assessed by self-report or electronic monitoring. Possible explanatory factors included age, beliefs regarding immunosuppressive drugs, depressive symptomatology, pre-emptive transplantation, and the number of transplants received, were also considered. Data were analyzed using logistic regression analysis. Results: Unadjusted non-adherence odds were 2 to 3 times higher in living-related than deceased donor transplantation (ORs: 2.09-3.05; p<0.05). Adjustment for confounders showed that these differences were associated most with the younger age of living-related subjects and the belief that immunosuppressive drugs are less important for living-related donations. Conclusion: There is a lower immunosuppressive adherence in recipients of living-related donor kidneys, possibly owing to differences in patient profile (ie, health beliefs regarding their immunosuppressive needs), knowledge of which may enhance adherence if addressed. Avicenna Organ Transplantation Institute 2014 2014-02-01 /pmc/articles/PMC4089329/ /pubmed/25013673 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Denhaerynck, K.
Schmid-Mohler, G.
Kiss, A.
Steiger, J.
Wüthrich, R. P.
Bock, A.
De Geest, S.
Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients
title Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients
title_full Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients
title_fullStr Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients
title_full_unstemmed Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients
title_short Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients
title_sort differences in medication adherence between living and deceased donor kidney transplant patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089329/
https://www.ncbi.nlm.nih.gov/pubmed/25013673
work_keys_str_mv AT denhaerynckk differencesinmedicationadherencebetweenlivinganddeceaseddonorkidneytransplantpatients
AT schmidmohlerg differencesinmedicationadherencebetweenlivinganddeceaseddonorkidneytransplantpatients
AT kissa differencesinmedicationadherencebetweenlivinganddeceaseddonorkidneytransplantpatients
AT steigerj differencesinmedicationadherencebetweenlivinganddeceaseddonorkidneytransplantpatients
AT wuthrichrp differencesinmedicationadherencebetweenlivinganddeceaseddonorkidneytransplantpatients
AT bocka differencesinmedicationadherencebetweenlivinganddeceaseddonorkidneytransplantpatients
AT degeests differencesinmedicationadherencebetweenlivinganddeceaseddonorkidneytransplantpatients